Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Alvar Loria-Acereto"'
Autor:
Alvar Loria-Acereto, Martha Kaufer-Horwitz, Elena Zambrano-González, Alejandra González-Duarte, Carlos A. Aguilar-Salinas, Juan Sierra-Madero, Virginia Pascual-Ramos
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 71(5)
Participants of Pharma-sponsored research are exposed to risks, benefits, and uncertainties that do not occur in other forms of clinical studies. Ethics committees represent the subjects' first line of protection. This responsibility begins with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::133a8e29b06dc8551c273da6c134084e
https://pubmed.ncbi.nlm.nih.gov/31599878
https://pubmed.ncbi.nlm.nih.gov/31599878
Autor:
Sergio Hernández-Jiménez, Alvar Loria-Acereto, Alvaro Aguayo-González, Alejandra González-Duarte, Carlos A. Aguilar-Salinas, Heriberto Medina-Franco, Martha Kaufer-Horwitz, Patricia Domínguez-Sánchez, Elena Zambrano, Jorge Oseguera-Moguel, Mauricio Sierra-Salazar, Marina Rull-Gabayet, Alejandra Armenta-Espinosa, Marta Durand-Carbajal, Josefina Alberú-Gómez, Arturo Galindo-Fraga, Carlos A. Hinojosa
Publikováno v:
Revista de investigaci�n Cl�nica. 71
It is often unclear to the clinical investigator whether observational studies should be submitted to a research ethics committee (REC), mostly because, in general, no active or additional interventions are performed. Moreover, obtaining an informed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27ab03e7dd4cb39c48c14695ae15ee22
https://doi.org/10.24875/ric.18002580
https://doi.org/10.24875/ric.18002580